The median value of GAPDH gene cfDII-fragmentation was found significant (p < 0.0001) in Kruskal–Wallis test among groups: healthy (7.412), CLD (6.233) and HCC (64.222) patients. This evidence concerns the gene GAPDH and hepatocellular carcinoma.